Novel macrocyclic peptides

Details Novel macrocyclic peptides Novel macrocyclic peptides

C - Chemistry, Metallurgy

07

K

C07K 7/64 (2006.01) A61K 38/13 (2006.01)

Patent

CA 2724523

Disclosed are cyclosporine derivatives in which the 3-Sarcosine carbon and 5- Valine nitrogen are each substituted by a non-hydrogen substituent, and their use as pharmaceuticals, in particular for the treatment of hepatitis C virus.

La présente invention concerne des dérivés de cyclosporine dans lesquels le carbone de la sarcosine-3 et lazote de la valine-5 sont chacun substitués par un substituant non-hydrogène, et leur utilisation en tant quagents pharmaceutiques, en particulier pour le traitement du virus de lhépatite C.

Affiliated with

Also associated with

Rating

Novel macrocyclic peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel macrocyclic peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel macrocyclic peptides will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1525403